OasisLMS

The Obesity Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Obesity Society designates this enduring material for a maximum of 78 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 13.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

ACCME Activity ID 203385711

Date of Release: January 15, 2026
Date of Termination: December 31, 2026

This enduring material of the live meeting received no commercial support from any ACCME defined ineligible company.

Ziyad Al-Aly: No Relevant Financial Relationships

Lydia Alexander: Advisor relationship with Novo Nordisk (Pharmaceuticals). Consultant relationship with Amgen (Pharmaceuticals). Speaker relationship with Eli Lilly (Pharmaceuticals).

Timothy Allerton: No Relevant Financial Relationships

Jaime Almandoz: Advisor relationship with AbbVie (Pharmaceuticals), Amgen (Pharmaceuticals), Boehringer Ingelheim (Pharmaceuticals), Eli Lilly (Pharmaceuticals), Kailera (Pharmaceuticals), Metsera (Pharmaceuticals), Novo Nordisk (Pharmaceuticals), Rhythm (Pharmaceuticals), and Rivus (Pharmaceuticals).

Amin Amin: No Relevant Financial Relationships

Michaela Anderson: Researcher relationship with United Therapeutics (Pharmaceuticals).

Jamy Ard: Advisor relationship with Amgen (Pharmaceuticals), Boehringer Ingelheim (Pharmaceuticals), Eli Lilly (Pharmaceuticals), Novo Nordisk (Pharmaceuticals), and Weight Watchers (Medical Food). Consultant relationship with Eli Lilly (Pharmaceuticals), Intuitive (Medical Device), Nestle Healthcare Nutrition (Medical Food), Regeneron (Pharmaceuticals), and WeightWatchers (Medical Food). In-Kind Support relationship with KVKTech (Pharmaceuticals), Nestle Healthcare Nutrition (Medical Food), and Weight Watchers (Medical Food). Researcher relationship with Amgen (Pharmaceuticals), Boehringer Ingelheim (Pharmaceuticals), Eli Lilly (Pharmaceuticals), Epitomee (Medical Device), KVKTech (Pharmaceuticals), and WeightWatchers (Medical Food).

Sarah Armstrong: No Relevant Financial Relationships

Louis Aronne: Advisor relationship with Altimmune (Pharmaceuticals), Atria (Biomedical), Boehringer-Ingelheim (Biomedical), CinFina Pharma (Pharmaceuticals), Corteria (Pharmaceuticals), Eli Lilly (Pharmaceuticals), MBX Bioscience (Biomedical), Jamieson Wellness (Pharmaceuticals), Janssen (Pharmaceuticals), Juvena Therapeutics (Pharmaceuticals), Kallyope (Biomedical), Pfizer (Pharmaceuticals),Novo Nordisk (Pharmaceuticals), Senda Biosciences (Biomedical), Skye Bio (Biomedical), Syntis Bio (Biomedical), Verdiva Bio (Biomedical), Versanis (Biomedical),and Zealand (Pharmaceuticals). Consultant relationship with Carmot Therapeutics (Biomedical), Currax Pharma (Pharmaceuticals), Enterin (Biomedical), Helicore Biopharma (Biomedical), Metsera (Biomedical), Morphic Medic / GI Dynamics (Medical Device), Novartis (Pharmaceuticals), Prosciento (Digital Health Platform), Summit Clinical (Clinical Research Platform), and Veru (Pharmaceuticals). Stock Options relationship with ERX (Pharmaceuticals), Kallyope (Biomedical), MBX Bioscience (Biomedical), Metsera (Biomedical), Skye Bio (Biomedical), Syntis Bio (Biomedical), Verdiva Bio (Biomedical), and Veru (Pharmaceuticals). Researcher relationship with AstraZeneca (Pharmaceuticals), Eli Lilly (Pharmaceuticals), Jamieson Wellness (Pharmaceuticals), Janssen (Pharmaceuticals), Novo Nordisk (Pharmaceuticals).

Dan Azagury: Advisor relationship with Endolumik (Medical Device), Form Health (Services), GI Windows (Medical Device), and Moon Surgical (Medical Device).

Sarah Barenbaum: No Relevant Financial Relationships

Jessica Bartfield: No Relevant Financial Relationships

John Batsis: Consultant relationship with Regeneron (Pharmaceuticals).

Heidi Bednarchuk: No Relevant Financial Relationships

Daniel Bessesen: Researcher relationship with Eli Lilly (Pharmaceuticals), Novo Nordisk (Pharmaceuticals), and Pfizer (Pharmaceuticals).

Lisa Beutler: Advisor relationship with Zealand Pharma (Pharmaceuticals). Stock relationship with Eli Lilly (Pharmaceuticals).

Mitch Biermann: Researcher relationship with Eli Lilly (Pharmaceuticals) and Novo Nordisk (Pharmaceuticals).

Tung Bui: No Relevant Financial Relationships

Kyle Burger: No Relevant Financial Relationships

E. Thomaseo Burton: No Relevant Financial Relationships

Omni Cassidy: No Relevant Financial Relationships

Kacey Chae: No Relevant Financial Relationships

Ariana Chao: Advisor relationship with Boehringer Ingelheim (Pharmaceuticals), Eli Lilly and Company (Pharmaceuticals), and Novo Nordisk (Pharmaceuticals).

Researcher relationship with Eli Lilly and Company (Pharmaceuticals).

Zoobia Chaudhry: No Relevant Financial Relationships

Alissa Chen: No Relevant Financial Relationships

Lawrence Cheskin: Consultant relationship with Aardvark Therapeutics (Pharmaceuticals). Stock relationship with Aardvark Therapeutics (Pharmaceuticals).

Karan Chhabra: Consultant relationship with GI Windows Surgical, LLC (Medical Device).

Shradha Chhabria: No Relevant Financial Relationships

Benjamin Chrisinger: No Relevant Financial Relationships

John Clark: No Relevant Financial Relationships

Stephen Cook: No Relevant Financial Relationships

Sarah Corapi: No Relevant Financial Relationships

Marc-Andre Cornier: Advisor relationship with Biophytis (Biomedical), Eli Lilly (Pharmaceuticals), Keros (Biomedical), Pfizer (Pharmaceuticals), Wave (Biomedical), and Zyversa (Biomedical). Consultant relationship with AstraZeneca (Pharmaceuticals). Data safety monitoring board relationship with Advarra (Pharmaceuticals). Researcher relationship with Amgen (Pharmaceuticals), Cleery (Biomedical), Ionis (Pharmaceuticals), Kaneka (Medical Device), and Novartis (Pharmaceuticals).

Florina Corpodean: No Relevant Financial Relationships

David Creel: No Relevant Financial Relationships

Javed Ahamed Cumbum Syed: No Relevant Financial Relationships

David Cummings: No Relevant Financial Relationships

Mariane De Oliveira: No Relevant Financial Relationships

Lea Decarie-Spain: No Relevant Financial Relationships

Fereshteh Dehghani: No Relevant Financial Relationships

Dimpi Desai: No Relevant Financial Relationships

Wiebke Diederich: No Relevant Financial Relationships

Alexandra DiFeliceantonio: No Relevant Financial Relationships

Manuel Dote Montero: No Relevant Financial Relationships

Carol Duh-Leong: No Relevant Financial Relationships

Roxanne Dupuis: No Relevant Financial Relationships

Cara Ebbeling: No Relevant Financial Relationships

Robert Eckel: Advisor relationship with Arrowhead (Pharmaceuticals), Madrigal (Pharmaceuticals), and Novo Nordisk (Pharmaceuticals). Consultant relationship with Amgen (Pharmaceuticals), Regeneron (Pharmaceuticals), Tolmar (Pharmaceuticals), and UpToDate (Biomedical). Speaker relationship with 89bio (Pharmaceuticals), Eli Lilly (Pharmaceuticals), Ionis (Pharmaceuticals), New Amsterdam (Pharmaceuticals), and Viatris (Pharmaceuticals).

Leonard Egede: No Relevant Financial Relationships

Alejandra Ellison-Barnes: No Relevant Financial Relationships

Joel Elmquist: Researcher relationship with Regeneron Pharmaceutical (Pharmaceuticals).

William Evans: No Relevant Financial Relationships

Anthony Ferrante: Researcher relationship with Boehringer-Ingelheim (Pharmaceuticals).

Lauren Fiechtner: No Relevant Financial Relationships

Allon Friedman: Advisor relationship with Eli Lilly (Pharmaceuticals), Gila Therapeutics (Biomedical), Morphic Medical (Medical Device), and Novo Nordisk (Pharmaceuticals). Site PI for clinical trial relationship with Eli Lilly (Biomedical).

Jeffrey Friedman: Royalties or Patent Beneficiary relationship with Chiesi (Pharmaceuticals). Stock relationship with Eli Lilly (Pharmaceuticals).

Christine Gallagher: Researcher relationship with Altimmune (Pharmaceuticals), Amgen (Pharmaceuticals), Boehringer Ingelheim (Pharmaceuticals), Currax (Pharmaceuticals), Eli Lilly (Pharmaceuticals), Found (Weight Management), Novo Nordisk (Pharmaceuticals), Pfizer (Pharmaceuticals), Structure Therapeutics (Pharmaceuticals), Wave Life Sciences (Pharmaceuticals), and Weight Watchers (Medical Food).

Adam Gilden: Researcher relationship with Eli Lilly (Pharmaceuticals).

Ayush Giri: No Relevant Financial Relationships

Victoria Goldman: No Relevant Financial Relationships

Rachel Goode: No Relevant Financial Relationships

Alyson Goodman: No Relevant Financial Relationships

Carlos Grilo: No Relevant Financial Relationships

Anna Grummon: No Relevant Financial Relationships

Kirk Habegger: Advisor relationship with Advance Therapeutics (Pharmaceuticals) and Boehringer Ingelheim (Pharmaceuticals). Consultant relationship with Genuiti Therapeutics (Pharmaceuticals) and Glyscend (Medical Device). Researcher relationship with Eli Lilly (Pharmaceuticals). Stock Options relationship with Glyscend (Medical Device).

Sajal Kumar Halder: No Relevant Financial Relationships

Kevin Hall: Consultant relationship with AstraZeneca (Pharmaceuticals), MacrosFirst (Medical Device), and WW (Medical Food).

Tanya Halliday: No Relevant Financial Relationships

C. Hatton: No Relevant Financial Relationships

Keally Haushalter: No Relevant Financial Relationships

Faith Anne Heeren: Consultant relationship with Weight Watchers (Medical Food). In-Kind Support relationship with American Academy of Pediatrics (Science).

Erin Hennessy: No Relevant Financial Relationships

Trent Herda: No Relevant Financial Relationships

Emily Hill: No Relevant Financial Relationships

James Hill: Advisor relationship with General Mills (Food).

Caroline Himbert: No Relevant Financial Relationships

Jay Horton: Advisor relationship with Merck (Pharmaceuticals). Consultant relationship with Abbvie (Pharmaceuticals), Aqur Biosciences (Pharmaceuticals), LG Chem Life Sciences Innovation Center (Pharmaceuticals), Pfizer (Pharmaceuticals), and Regeneron (Pharmaceuticals).

Daniel Hsia: Advisor relationship with Eli Lilly and Company (Pharmaceuticals).

Sophia Hua: No Relevant Financial Relationships

Zach Hutelin: No Relevant Financial Relationships

Jennifer Hwang: No Relevant Financial Relationships

Talat Ikizler: Speaker relationship with Fresenius Kabi (Biomedical).

Kellene Isom: No Relevant Financial Relationships

Valentina Ivezaj: Consultant relationship with Optum (Biomedical).

Yu Mi Kang: No Relevant Financial Relationships

Harsha Karanchi: No Relevant Financial Relationships

Ju Hee Kim: No Relevant Financial Relationships

Samuel Klein: Advisor relationship with Altimmune (Pharmaceuticals), Boehringer Ingelheim (Pharmaceuticals), and Merck (Pharmaceuticals). Consultant relationship with Alnylam (Pharmaceuticals).

Alicia Kunin-Batson: No Relevant Financial Relationships

Robert Kushner: Advisor relationship with Abbvie (Pharmaceuticals), Antag (Pharmaceuticals), Astra Zeneca (Pharmaceuticals), Currax (Pharmaceuticals), Eli Lilly (Pharmaceuticals), Novo Nordisk (Pharmaceuticals), and WW (Medical Food). Consultant relationship with Altimmune (Pharmaceuticals), Boehringer Ingelheim (Pharmaceuticals), Regeneron (Pharmaceuticals), and Structure (Pharmaceuticals).

Ian Lanza: No Relevant Financial Relationships

Tashara Leak: No Relevant Financial Relationships

David Lefer: No Relevant Financial Relationships

Dominick Lemas: No Relevant Financial Relationships

Kristina Lewis: Advisor relationship with NovoNordisk (Pharmaceuticals). NIH funded trial relationship with KVK Tech (Pharmaceuticals).

Soo Lim: Advisor relationship with CKD (Pharmaceuticals). Speaker relationship with AstraZeneca (Pharmaceuticals), Boehringer Ingelheim (Pharmaceuticals), Daewoong (Pharmaceuticals), Eli Lilly (Pharmaceuticals), GSK (Pharmaceuticals), LG Chem (Pharmaceuticals), Novo Nordisk (Pharmaceuticals), and Servier (Pharmaceuticals).

Kate Lofgren: No Relevant Financial Relationships

Michelle Look: Advisor relationship with Boehringer Ingelheim (Pharmaceuticals), Eli Lilly (Pharmaceuticals), and Novo Nordisk (Pharmaceuticals). Speaker relationship with Eli Lilly (Pharmaceuticals).

Janet Lydecker: No Relevant Financial Relationships

Gina Many: No Relevant Financial Relationships

Corby Martin: Advisor relationship with EHE Health (Health Care Provider) and Wondr Health (Weight Management). Consultant relationship with Almond Board of California (Food), Medifast (Medical Food), and Zealand Pharma (Pharmaceuticals). Researcher relationship with Boehringer Ingelheim (Pharmaceuticals), Eli Lilly (Pharmaceuticals), Novo Nordisk (Pharmaceuticals), Spoonified (Food), and WW (Medical Food). Royalties or Patent Beneficiary relationship with Access Business Group (Weight Management).

Susan McElroy: Consultant relationship with Axsome (Pharmaceuticals), Idorsia (Pharmaceuticals), Kallyope (Pharmaceuticals), Levo (Pharmaceuticals), Novo Nordisk (Pharmaceuticals), Otsuka (Pharmaceuticals), Soleno (Pharmaceuticals), and Sunovion (Pharmaceuticals).

Researcher relationship with Axsome (Pharmaceuticals), Neurocrine (Pharmaceuticals), and Otsuka (Pharmaceuticals).

David Mendoza: No Relevant Financial Relationships

Daniel Mensah: No Relevant Financial Relationships

Abigail Metzler: No Relevant Financial Relationships

Jaime Moore: No Relevant Financial Relationships

Aviva Musicus: No Relevant Financial Relationships

Kalpana Muthusamy: Researcher relationship with Endogenex (Biomedical) and Regeneron (Pharmaceuticals).

Mandar Muzumdar: No Relevant Financial Relationships

Chiadi Ndumele: No Relevant Financial Relationships

Linhda Nguyen: Consultant relationship with Novo Nordisk (Pharmaceuticals).

Yan Ni: No Relevant Financial Relationships

Sally Omidvar: No Relevant Financial Relationships

Stephen O'Rahilly: Advisor relationship with Marea Therapeutics (Pharmaceuticals) and Pfizer (Pharmaceuticals). Stock Options relationship with Marea Therapeutics (Pharmaceuticals). Researcher relationship with GSK (Pharmaceuticals).

Babak Orandi: Advisor relationship with Boehringer Ingelheim (Pharmaceuticals).

Chigolum Oyeka: No Relevant Financial Relationships

Matthew Paponetti: No Relevant Financial Relationships

Megan Parker: No Relevant Financial Relationships

Elizabeth Parks: Advisor relationship with Simply Good (Food). Consultant relationship with Corcept (Pharmaceuticals).

Robyn Pashby: No Relevant Financial Relationships

Michele Patel: No Relevant Financial Relationships

Elizabeth Paul: Advisor relationship with Boehringer Ingelheim (Pharmaceuticals) and Pfizer (Pharmaceuticals). Speaker relationship with AmGen (Pharmaceuticals), Eli Lilly (Pharmaceuticals), Genetech (Pharmaceuticals), and Structure Theraputics (Pharmaceuticals).

Nicole Pearce: No Relevant Financial Relationships

Anna Pendrey: No Relevant Financial Relationships

Joshua Petimar: No Relevant Financial Relationships

Cash Petree: No Relevant Financial Relationships

Paolo Piaggi: No Relevant Financial Relationships

Michael Ponte: No Relevant Financial Relationships

Barry Popkin: No Relevant Financial Relationships

Lisa Powell: No Relevant Financial Relationships

Carla Prado: Consultant relationship with Nutricia (Medical Food). Speaker relationship with Abbott Nutrition (Medical Food), Nestle Health Sciences (Medical Food), and Novo Nordisk (Pharmaceuticals).

Rhonda Pruitt: No Relevant Financial Relationships

Rana Pullatt: Speaker relationship with Conmed (Medical Device), Intuitive Surgical (Medical Device), and Medtronic (Medical Device).

Jonathan Purnell: Advisor relationship with Boehringer Ingelheim (Pharmaceuticals) and Luciole (Pharmaceuticals). Consultant relationship with Novo Nordisk (Pharmaceuticals) and Regeneron (Pharmaceuticals). Research Grant Funding Support relationship with NICHD/NIH (Government).

Nancy Puzziferri: Advisor relationship with NovoNordisk (Pharmaceuticals).

Ritika Raghavan: No Relevant Financial Relationships

Johanna Ralston: No Relevant Financial Relationships

Erika Rees-Punia: No Relevant Financial Relationships

Evan Reynolds: No Relevant Financial Relationships

Angela Ritten: Speaker relationship with Currax (Pharmaceuticals) and Lilly (Pharmaceuticals).

Renee Rogers: Advisor relationship with AstraZeneca (Pharmaceuticals). Consultant relationship with Wondr Health (Weight Management). Educational relationship with Seca (Medical Device).

Barbara Rolls: No Relevant Financial Relationships

Alexandra Ross: No Relevant Financial Relationships

Michele Rouse: No Relevant Financial Relationships

Donna Ryan: Advisor relationship with Abbvie (Pharmaceuticals), Altimmune (Pharmaceuticals), Amgen (Pharmaceuticals), AstraZeneca (Pharmaceuticals), Biohaven (Pharmaceuticals), Boehringer Ingelheim (Pharmaceuticals), Calibrate (Biomedical), Carmot (Pharmaceuticals), Cin RX (Pharmaceuticals), Currax (Pharmaceuticals), Eli Lilly (Pharmaceuticals), eMed (Biomedical), Epitomee (Medical Device), Nestle (Medical Food), Regeneron (Pharmaceuticals), Scientific Intake (Medical Device), Structure Therapeutics (Pharmaceuticals), Tenvie (Pharmaceuticals), Wondr Health (Biomedical), and Zealand (Pharmaceuticals). Consultant relationship with Source Bio (Pharmaceuticals). Data Monitoring Committee relationship with Cin RX (Pharmaceuticals) and Eli Lilly (Pharmaceuticals). Research relationship with Novo Nordisk (Pharmaceuticals). Speaker relationship with Eli Lilly (Pharmaceuticals) and Novo Nordisk (Pharmaceuticals). Stock Options relationship with Epitomee (Medical Device) and Scientific Intake (Medical Device).

Amin Sabet: Stock relationship with Abbott Labs (Pharmaceuticals), AbbVie Inc (Pharmaceuticals), Eli Lilly (Pharmaceuticals), Johnson & Johnson (Pharmaceuticals), Merck & Co (Pharmaceuticals), and Novo Nordisk (Pharmaceuticals).

Darleen Sandoval: No Relevant Financial Relationships

Philipp Scherer: No Relevant Financial Relationships

Laura Schmidt: No Relevant Financial Relationships

Camille Schneider- Worthington: No Relevant Financial Relationships

Jessica Schwartz: Researcher relationship with Novo Nordisk (Pharmaceuticals).

Bruce Scott: No Relevant Financial Relationships

Mireille Serlie: Researcher relationship with Appo (Distributes parenteral nutrition and medication to patients), Novo Nordisk (Pharmaceuticals), and Takeda (Pharmaceuticals).

Lisa Shank: No Relevant Financial Relationships

Amod Sharma: No Relevant Financial Relationships

Arya Sharma: Advisor relationship with Abbvie (Pharmaceuticals), AstraZeneca (Pharmaceuticals), Bayer (Pharmaceuticals), Boehringer Ingelheim (Pharmaceuticals), Eli Lilly (Pharmaceuticals), and Novo Nordisk (Pharmaceuticals). Speaker relationship with Currax (Pharmaceuticals), Eli Lilly (Pharmaceuticals), Novo Nordisk (Pharmaceuticals).

Yun Shen: No Relevant Financial Relationships

Sepideh Sheybani Deluoui: No Relevant Financial Relationships

Melissa Shoemaker: No Relevant Financial Relationships

Karolina Skibicka: No Relevant Financial Relationships

Lauren Sparks: No Relevant Financial Relationships

Amanda Staiano: No Relevant Financial Relationships

Fatima Stanford: Advisor relationship with Apnimed (Biomedical), Boehringer Ingelheim (Pharmaceuticals), Calibrate (Weight Management), Clearmind Medicine (Pharmaceuticals), Currax (Pharmaceuticals), Eli Lilly (Pharmaceuticals), Empros Pharma (Pharmaceuticals), Ilant Health (Biomedical), Lifeforce (Biomedical), Mellicell (Pharmaceuticals), Novo Nordisk (Pharmaceuticals), Pfizer (Pharmaceuticals), and Vida Health (Biomedical). Consultant relationship with Astra Zeneca (Pharmaceuticals).

Matthew Steinhauser: No Relevant Financial Relationships

Sarah Stewart: No Relevant Financial Relationships

Paul Stolin: No Relevant Financial Relationships

Marian Tanofsky-Kraff: No Relevant Financial Relationships

Beverly Tchang: Advisor relationship with Amgen (Pharmaceuticals), Boehringer- Ingelheim (Pharmaceuticals), Eli Lilly (Pharmaceuticals), Metsera (Pharmaceuticals), Novo Nordisk (Pharmaceuticals), Roche (Pharmaceuticals), Roman Health Ventures (Pharmaceuticals), Skye Bioscience (Pharmaceuticals), and Tern (Pharmaceuticals). Stock Options relationship with Roman Health Ventures (Pharmaceuticals).

Vidhu Thaker: Independent Contractor relationship with Rhythm (Pharmaceuticals). Speaker relationship with Rhythm (Pharmaceuticals).

Arianne Theiss: No Relevant Financial Relationships

Grant Tinsley: Advisor relationship with Legion Athletics, Inc. (Supplement) and Prism Labs (Medical Device). Researcher relationship with Bunge Loders Croklaan (Supplement), EHP Labs (Supplement), Prism Labs (Medical Device), and Size Stream LLC (Medical Device). Royalties or Patent Beneficiary relationship with Metabolic Technologies (Supplement). Stock relationship with Altimmune (Pharmaceuticals), Globus Medical (Medical Device), and Prism Labs (Medical Device).

Deirdre Tobias: Researcher relationship with Montai Health Inc (Biomedical).

Mabel Toribio: Researcher relationship with Caristo (Biomedical) and Novartis (Pharmaceuticals).

Lisa Tritto: No Relevant Financial Relationships

Ana Valencia: No Relevant Financial Relationships

Krista Varady: No Relevant Financial Relationships

Amanda Velazquez: Advisor relationship with Weight Watchers (Medical Food) Consultant relationship with Eli Lilly (Pharmaceuticals) and Novo Nordisk (Pharmaceuticals).

Clay Venetis: No Relevant Financial Relationships

Alison Ventura: No Relevant Financial Relationships

Jose Villamarin: No Relevant Financial Relationships

Rebekah Walker: No Relevant Financial Relationships

Katie Whytock: No Relevant Financial Relationships

Denise Wilfley: No Relevant Financial Relationships

Kevin Williams: Stock relationship with Eli Lilly (Pharmaceuticals) and Novo Nordisk (Pharmaceuticals).

Hanieh Yaghootkar: Researcher relationship with Calico Life Sciences (Biomedical).

Masha Yemets: No Relevant Financial Relationships

Adnin Zaman: No Relevant Financial Relationships

Tonya Zeiger: No Relevant Financial Relationships

Evan Zeitler: Consultant relationship with Novo Nordisk (Pharmaceuticals).

Jeffrey Zigman: Stock relationship with Eli Lilly (Pharmaceuticals), Novo Nordisk (Pharmaceuticals), and Medtronic (Medical Device).

Vance Albaugh T2: Neuroscience: Researcher relationship with Johnson & Johnson (Pharmaceuticals). Speaker relationship with Novo Nordisk (Pharmaceuticals).

Timothy Allerton T1: Metabolism/Integrative Physiology Chair: No Relevant Financial Relationships

Gretchen Ames T5: Clinical/Professional Practice: No Relevant Financial Relationships

John Apolzan T3: Intervention/Clinical Studies: No Relevant Financial Relationships

Julio Ayala T2: Neuroscience: No Relevant Financial Relationships

Katherine Balantekin T4: Population Health: No Relevant Financial Relationships

John Batsis T3: Intervention/Clinical Studies Chair: Consultant relationship with Regeneron (Pharmaceuticals).

Sherlyn Celone-Arnold TOS CEO starting 6/1/25: No Relevant Financial Relationships

John Clark T6: Policy/Public Health Chair: No Relevant Financial Relationships

John Cleek T5: Clinical/Professional Practice Co-Chair: Speaker relationship with Eli Lilly (Pharmaceuticals) and Novo Nordisk (Pharmaceuticals).

Anthony Comuzzie TOS CEO until 5/30/25: No Relevant Financial Relationships

Marc-Andre Cornier Liaison: Advisor relationship with Biophytis (Biomedical), Eli Lilly (Pharmaceuticals), Keros (Biomedical), Pfizer (Pharmaceuticals), Wave (Biomedical), and Zyversa (Biomedical). Consultant relationship with AstraZeneca (Pharmaceuticals). Data safety monitoring board relationship with Advarra (Pharmaceuticals). Researcher relationship with Amgen (Pharmaceuticals), Cleery (Biomedical), Ionis (Pharmaceuticals), Kaneka (Medical Device), and Novartis (Pharmaceuticals).

Tiffany Cortes T5: Clinical/Professional Practice: Researcher relationship with CJ-Cheil- Jedang-Corporation (Medical Supplement).

Lara Dugas T4: Population Health: No Relevant Financial Relationships

Mary Evans T4: Population Health Chair: No Relevant Financial Relationships

Jonathan Flak T2: Neuroscience Chair: Researcher relationship with Eli Lilly (Pharmaceuticals).

Laura Goetz T5: Clinical/Professional Practice Chair: No Relevant Financial Relationships

Barbara Gower T1: Metabolism/Integrative Physiology: Consultant relationship with Simply Good Foods (Food)

Anna Grummon T6: Policy/Public Health: No Relevant Financial Relationships

Kimberly Gudzune T3: Intervention/Clinical Studies: Advisor relationship with Eli Lilly (Pharmaceuticals) and Novo Nordisk (Pharmaceuticals).

Ross Hammond T6: Policy/Public Health Co- Chair: No Relevant Financial Relationships

Deborah Horn T5: Clinical/Professional Practice: Consultant relationship with Amgen (Pharmaceuticals), Astra Zeneca (Pharmaceuticals), Boehringer Ingelheim (Pharmaceuticals), Eli Lilly (Pharmaceuticals), Novo Nordisk (Pharmaceuticals), and Zealand (Pharmaceuticals). Researcher relationship with Eli Lilly (Pharmaceuticals). Speaker relationship with Novo Nordisk (Pharmaceuticals).

Daniela Hurtado Andrade T3: Intervention/Clinical Studies: Consultant relationship with Novo Nordisk (Pharmaceuticals). Researcher relationship with Endogenex (Biomedical) and Phenomix (Biomedical).

Maren Laughlin T1: Metabolism/Integrative Physiology: No Relevant Financial Relationships

E. Matthew Morris T1: Metabolism/Integrative Physiology: Stock relationship with Abbott Laboratories (Biomedical), Eli Lilly (Pharmaceuticals), Johnson & Johnson (Pharmaceuticals) , Merck (Pharmaceuticals), and Novartis (Pharmaceuticals).

Ana Palacios T6: Policy/Public Health: Researcher relationship with Weight Watchers (Medical Food).

Alpa Patel T4: Population Health: No Relevant Financial Relationships

Joshua Petimar T6: Policy/Public Health: No Relevant Financial Relationships

Sebastian Salathe T1: Metabolism/Integrative Physiology: No Relevant Financial Relationships

Robert Siegel T4: Population Health Co- Chair: No Relevant Financial Relationships

Joseph Skelton T3: Intervention/Clinical Studies Co-Chair: No Relevant Financial Relationships

John Thyfault Co-Chair: No Relevant Financial Relationships

Kristy Townsend T2: Neuroscience: No Relevant Financial Relationships

Saroja Voruganti T1: Metabolism/Integrative Physiology Co-Chair: No Relevant Financial Relationships

Kevin Williams T2: Neuroscience Co-Chair: Stock relationship with Eli Lilly (Pharmaceuticals) and Novo Nordisk (Pharmaceuticals).

Susan Yanovski Chair: No Relevant Financial Relationships during conference planning. Added Speaker relationship with Eli Lilly in July 2025.

No members of the TOS CME Oversight Committee, charged with the resolution of all relevant conflicts of interest, had any relevant financial relationships while serving on the committee.

1. https://www.annualreviews.org/content/journals/10.1146/annurev-pharmtox-031124-101146 Ariana M. Chao1, Simeon Taylor2, Molly Moore3, Anastassia Amaro4, and Thomas A. Wadden3; Evolving Approaches for Pharmacological Therapy of Obesity; Vol. 65:169-189 (Volume publication date January 2025)
2. Eisenberg D, Shikora SA, Aarts E, et al. 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery [published correction appears in Obes Surg. 2022 Nov 29;:]. Obes Surg. 2023;33(1):3-14. doi:10.1007/s11695-022-06332-1
3. CM Apovian “The Obesity Epidemic – Understanding the Disease and the Treatment.” N Engl J Med 2016; 374:177-179

4. PR Schauer et al “Bariatric Surgery versus Intensive medical therapy for Diabetes - 5–year outcomes.” N Engl J Med 2017; 376:641-651
5. JS Yeh et al. “Obesity and Management of Weight Loss.” N Engl J Med 2016; 375:1187-1189
6. E LeBlanc, C Patnode, E Webber, et al "Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults Updated Evidence Report and Systematic Review for the US Preventive Services Task Force." JAMA. 2018;320(11):1172-1191 doi:10.1001/jama.2018.7777
7. The physiological control of eating: signals, neurons, and networks. Watts AG, Kanoski SE, Sanchez-Watts G, Langhans W. Physiol Rev. 2022 Apr 1;102(2):689-813. doi: 10.1152/physrev.00028.2020. Epub 2021 Sep 6. PMID: 34486393
8. Functions of Interoception: From Energy Regulation to Experience of the Self. Quigley KS, Kanoski S, Grill WM, Barrett LF, Tsakiris M. Trends Neurosci. 2021 Jan;44(1):29-38. doi: 10.1016/j.tins.2020.09.008. PMID: 33378654
9. Louis J Aronne 1, Kevin D Hall 2, John M Jakicic 3, Rudolph L Leibel 4, Michael R Lowe 5, Michael Rosenbaum 4, Samuel Klein 6 “Describing the Weight-Reduced State: Physiology, Behavior, and Interventions”. Obesity (Silver Spring). 2021 Apr;29 Suppl 1(Suppl 1): S9-S24. doi: 10.1002/oby.23086.
10. SB Heymsfield and TA Wadden “Mechanisms, Pathophysiology, and Management of Obesity.” N Engl J Med 2017;376:254-266
11. MW Schwartz, RJ Seeley, LM Zeltser, A Drewnowski, E Ravussin, LM Redman, RL Leibel “Obesity Pathogenesis.” Endocr Rev. 2017 Aug 1;38(4):267-296.
12. AG Tsai et all, “Evidence of a Gap in Understanding, Obesity Among Physicians.” Obesity, Science and Practice Online 1/12/18, DOI: 10/1002/asp4.416
13. MacLean PS, Rothman AJ, Nicastro HL, Czajkowski SM, Agurs-Collins T, Rice EL, Courcoulas AP, Ryan DH, Bessesen DH, Loria CM. The Accumulating Data to Optimally Predict Obesity Treatment (ADOPT) Core Measures Project: Rationale and Approach. Obesity (Silver Spring). 2018 Apr;26 Suppl 2: S6-S15. doi: 10.1002/oby.22154.
14. Hampl SE, Hassink SG, Skinner AC, et al. “Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity” [published online ahead of print, 2023 Jan 9]. Pediatrics. 2023;e2022060640. doi:10.1542/peds.2022-060640.
15. https://www.thelancet.com/journals/landia/article/PIIS2213-8587(22)00047-X/fulltext
16. Hiba Jebeile, PhDa,b ∙ Prof Aaron S Kelly, PhDd ∙ Grace O'Malley, PhDe,f ∙ Prof Louise A Baur, PhD; Obesity in children and adolescents: epidemiology, causes, assessment, and management; Volume 10, Issue 5p351-365, May 2022
17. US Preventive Services Task Force, Nicholson WK, Silverstein M, et al. Interventions for High Body Mass Index in Children and Adolescents: US Preventive Services Task Force Recommendation Statement. JAMA 2024; 332:226.
18. O'Connor EA, Evans CV, Henninger M, et al. Interventions for Weight Management in Children and Adolescents: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2024; 332:233.
19. Heerman WJ, Rothman RL, Sanders LM, et al. A Digital Health Behavior Intervention to Prevent Childhood Obesity: The Greenlight Plus Randomized Clinical Trial. JAMA 2024; 332:2068.
20. Hampl SE, Hassink SG, Skinner AC, et al. Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity. Pediatrics. 2023;151(2): e2022060640
21. J Pratt, A Browne, N Browne, M Bruzoni, M Cohen, A Desai, T Inge, B Linden, S Mattar, M Michalsky, D Podkammeni, K Reichard, F Cody Stanford, M Zeller, J Zitsman "ASMBS Pediatric Metabolic and Bariatric Surgery Guidelines,2018" Surgery for Obesity and Related Diseases 2018: 14: 882-901.
22. G Srivastava, C Fox, A Kelly, A Jastreboff, A Browne, N Browne, J Pratt, C Bolling, M Michalsky, S Cook, C Lenders, C Apovian "Clinical Considerations Regarding the Use of Obesity Pharmacotherapy in Adolescents with Obesity" Obesity 24 Jan 2019: 27: 190-204.
23. Cardel M, Jastreboff AM, Kelly A. Treatment of Adolescent Obesity in 2020. JAMA Insights. 2019 September 30.

24. Talumaa, B., Brown, A., Batterham, R. L., & Kalea, A. Z. (2022). Effective strategies in ending weight stigma in healthcare. Obesity Reviews, 23(10), e13494.
25. Puhl, R. M., Himmelstein, M. S., & Pearl, R. L. (2020). “Weight stigma as a psychosocial contributor to obesity”. American Psychologist, 75(2), 274–289. https://doi.org/10.1037/amp0000538
26. Pamela L Thornton 1, Shiriki K Kumanyika 2, Edward W Gregg 3, Maria R Araneta 4, Monica L Baskin 5, Marshall H Chin 6, Carlos J Crespo 7, Mary de Groot 8, David O Garcia 9, Debra Haire-Joshu 10, Michele Heisler 11, Felicia Hill- Briggs 12, Joseph A Ladapo 13, Nangel M Lindberg 14, Spero M Manson 15, David G Marrero 16, Monica E Peek 6, Alexandra E Shields 17, Deborah F Tate 18, Carol M Mangione 19 “New research directions on disparities in obesity and type 2 diabetes” 2020 Feb;1461(1):5-24. doi: 10.1111/nyas.14270. Epub 2019 Dec 3.
27. AcQasim, M Turcotte, RJ de Souza, MC Samaan, D Champredon, J Dushoff, JR Speakman, D Meyre “On the origin of obesity: identifying the biological, environmental and cultural drivers of genetic risk among human populations.” Obes Rev. 2018 Feb;19(2):121-149.
28. N Hayba, SR Partridge, MM Nour, A Grech, M Allman Farinelli “Effectiveness of lifestyle interventions for preventing harmful weight gain among young adults from lower socioeconomic status and ethnically diverse backgrounds: a systematic review.” Obes Rev. 2017 Nov 26.
29. GC Porter, K Laumb, T Michaud, F Brito, D Petreca, G Schwieger, T Bartee, KHK Yeary, PA Estabrooks "Understanding the impact of rural weight loss interventions: A systematic review and meta-analysis." Obes Rev. 2019 Jan 11. doi: 10.1111/obr.12825.
30. G Chen, A Doumatey, J Zhou, L Lei, A Bentley, O Fasanmade, G Okafor, B Eghan Jr, K Agyenim-Boateng, A Amoah, C Adebamowo, J Acheampong, T Johnson, J Oli, D Shriner, A Adeyemo, and C Rotimi1 "Genome-wide analysis identifies an African- specific variant in SEMA4D that is associated with Body Mass Index." Obesity 2017 April ; 25(4): 794–800. doi:10.1002/oby.21804.
31. National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Food and Nutrition Board, Roundtable on Obesity Solutions. “The Challenge of Treating Obesity and Overweight: Proceedings of a Workshop.” Washington (DC): National Academies Press (US); 2017 Dec 21.
32. SB Heymsfield and TA Wadden “Mechanisms, Pathophysiology, and Management of Obesity.” N Engl J Med 2017;376:254-266
33. JS Yeh et al. “Obesity and Management of Weight Loss.” N Engl J Med 2016; 375:1187-1189
34. DA Williamson “Fifty Years of Behavioral/Lifestyle Interventions for Overweight and Obesity: Where Have We Been and Where Are We Going?” Obesity (Silver Spring). 2017 Nov;25(11):1867-1875.
35. E LeBlanc, C Patnode, E Webber, et al "Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults Updated Evidence Report and Systematic Review for the US Preventive Services Task Force." JAMA. 2018;320(11):1172-1191. doi:10.1001/jama.2018.7777
36. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck,

M. C., Stefanski, A., & SURMOUNT-1 Investigators. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. The New England Journal of Medicine, 387(3), July 21, 2022.
37. Wadden, T. A., Chao, A. M., Machineni, S., Kushner, R., Ard, J., Srivastava, G., Halpern, B., Zhang, S., Chen, J., Bunck,

M. C., Ahmad, N. N., & Forrester, T. (2023). Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial. Nature Medicine, 29, 2909–2918. Published online: 15 October 2023. https://doi.org/10.1038/s41591-023-02597-w
38. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., & Kushner, R. F., for the STEP 1 Study Group. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. The New England Journal of Medicine, 384(11), 989-1002. DOI: 10.1056/NEJMoa2032183

39. Wadden, T. A., Chao, A. M., Machineni, S., Kushner, R., Ard, J., Srivastava, G., Halpern, B., Zhang, S., Chen, J., Bunck,

M. C., Ahmad, N. N., & Forrester, T. (2023). Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial. Nature Medicine, 29, 2909–2918. Published online: 15 October 2023. https://doi.org/10.1038/s41591-023-02597-w
40. Elmaleh-Sachs A, et al. Obesity Management in Adults: A Review. JAMA 2023; 330(20):2000-15. PMID: 38015216.
41. DE Wilfley, AE Staiano, M Altman, J Lindros, A Lima, SG Hassink, WH Dietz, S Cook “Improving Access and Systems of Care for Evidence-Based Childhood Obesity Treatment Conference Workgroup.” Obesity (Silver Spring). 2017 Jan;25(1):16-29.
42. C Baum, K Andino, E Wittbrodt, S Stewart, K Szymanski, R Turpin “The Challenges and Opportunities Associated with Reimbursement for Obesity Pharmacotherapy in the USA” Pharmacoeconomics. 2015 Jul;33(7):643-53.
43. AS Chawla, CW Hsiao, MC Romney, R Cohen, F Rubino, P Schauer, P Cremieux “Gap Between Evidence and Patient Access: Policy Implications for Bariatric and Metabolic Surgery in the Treatment of Obesity and its Complications.” Pharmacoeconomics. 2015 Jul;33(7):629-41.
44. N Jannah, J Hild, C Gallagher, and W Dietz "Coverage for Obesity Prevention and Treatment Services: Analysis of Medicaid and State Employee Health Insurance Programs" Obesity 2018 Dec; 26(12): 1834-1840.
45. Salminen P, et al. IFSO Consensus on Definitions and Clinical Practice Guidelines for Obesity Management-an International Delphi Study. Obes Surg. 2024; 34(1): 30-42. PMID: 37999891.